Bangkok Dusit Medical Services stock faces a Q2 profit decline

Bangkok Dusit Medical Services stock follows Q2 net income of THB 3.25 billion. July patient revenue and international bookings improved, while the SET quote was THB 19.20.

Bangkok Dusit Medical Services stock faces a Q2 2026 profit decline as net income fell 7.00 percent year over year to THB 3.25 billion, according to EdgeChat. The result contrasts with operating income of THB 27.51 billion, which rose 1.00 percent in the quarter, keeping patient demand and cost control at the center of the stock story.

Q2 profit falls as revenue edges higher

The Q2 2026 result shows a mixed operating picture. Net income reached THB 3.25 billion, while consolidated operating income rose 1.00 percent to THB 27.51 billion, according to EdgeChat. The earnings decline therefore came alongside continued top-line growth, making margins and the revenue mix more important than headline sales alone.

Financial ratios for Q2 2026 show total revenue growth of 4.84 percent and net profit growth of 5.78 percent on the year-to-date quarterly presentation, efin.finance reports. The different measures underline why investors need to distinguish the single-quarter result from the cumulative reporting view.

International demand supplies the counterweight

July brought stronger patient trends in the latest analyst research. Thai patient revenue rose 9.00 percent year over year, international patient revenue increased 6.00 percent, and insured-patient revenue grew 11.00 percent, according to POEMS on September 2, 2026.

International patient bookings rose from more than 30,000 to more than 40,000 between April and August 2026, a 33.00 percent increase, the same research report states. BDMS is also adding 44 beds at Bangkok Hospital Surat and 50 beds at Bangkok Hospital Hua Hin, tying capacity expansion to identified demand rather than a broad network rollout.

POEMS maintained a BUY recommendation and a THB 25.00 target price on September 2, 2026. Against the SET quote of THB 19.20, that target is THB 5.80 higher, or 30.21 percent above the market price, but the Q2 profit decline remains the key counterweight to the recovery thesis.

SET quote stays below yearly high

BDMS was last at THB 19.20 on the SET on October 1, 2026 at 11:15 a.m. ICT. The market capitalization was THB 305.1 billion, while the 52-week range stood at THB 17.40 to THB 22.40, placing the share below its yearly high and above its yearly low.

Bangkok Dusit Medical Services stock facts

• Company: Bangkok Dusit Medical Services Public Company Limited
• Ticker: BDMS
• Primary exchange: SET
• Price on SET (as of October 1, 2026, 11:15 a.m. ICT): THB 19.20
• Market capitalization: THB 305.1 billion (as of October 1, 2026)
• 52-week range: THB 17.40-22.40 (as of October 1, 2026)
• Sector / Industry: Healthcare / Medical Care Facilities
• Index membership: SET50, SET100 and SETCLMV